STAT3-confusion-of-function: Beyond the loss and gain dualism.

STAT3 STAT3 gain-of-function STAT3 loss-of-function Sjögren syndrome T(H)17 cells hyper-IgE syndrome inborn error of immunity

Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 09 01 2022
revised: 23 05 2022
accepted: 14 06 2022
pubmed: 25 6 2022
medline: 9 11 2022
entrez: 24 6 2022
Statut: ppublish

Résumé

Germline mutations of signal transducer and activator of transcription 3 (STAT3) are responsible for 2 distinct human diseases: autosomal-dominant hyper-IgE syndrome (AD-HIES) caused by STAT3 loss-of-function mutations and STAT3 gain-of-function disease. So far, these entities have been regarded as antithetic, with AD-HIES mainly associated with characteristic infections and a connective tissue phenotype and STAT3 gain-of-function characterized by lymphoproliferation and poly-autoimmunity. The R335W substitution in the DNA-binding domain of STAT3 was initially described in 2 patients with typical AD-HIES, but paradoxically, recent functional analysis demonstrated a gain-of-function effect of this variant. A patient with Sjögren syndrome and features of AD-HIES with this mutation is described and the molecular consequences are further characterized. This study provides a clinical and immunological description of the patient. STAT phosphorylation in primary patient cells was studied and A4 cells transfected with the patient allele were used to study phosphorylation kinetics, transcriptional activity, and target-gene induction. The hybrid clinical features of the patient were associated with normal T The germline R335W-STAT3 variant displays a mixed behavior in vitro that mainly shows gain-of-function, but also loss-of-function features. This is matched by an ambiguous clinical and immunological phenotype that dismantles the classical antithetic dualism of gain- versus loss-of-function. Germline STAT3 mutation-related disease represents a pathological spectrum with the p.R335W associated phenotype locating between the 2 recognized clinical disease patterns.

Sections du résumé

BACKGROUND
Germline mutations of signal transducer and activator of transcription 3 (STAT3) are responsible for 2 distinct human diseases: autosomal-dominant hyper-IgE syndrome (AD-HIES) caused by STAT3 loss-of-function mutations and STAT3 gain-of-function disease. So far, these entities have been regarded as antithetic, with AD-HIES mainly associated with characteristic infections and a connective tissue phenotype and STAT3 gain-of-function characterized by lymphoproliferation and poly-autoimmunity. The R335W substitution in the DNA-binding domain of STAT3 was initially described in 2 patients with typical AD-HIES, but paradoxically, recent functional analysis demonstrated a gain-of-function effect of this variant.
OBJECTIVES
A patient with Sjögren syndrome and features of AD-HIES with this mutation is described and the molecular consequences are further characterized.
METHODS
This study provides a clinical and immunological description of the patient. STAT phosphorylation in primary patient cells was studied and A4 cells transfected with the patient allele were used to study phosphorylation kinetics, transcriptional activity, and target-gene induction.
RESULTS
The hybrid clinical features of the patient were associated with normal T
CONCLUSIONS
The germline R335W-STAT3 variant displays a mixed behavior in vitro that mainly shows gain-of-function, but also loss-of-function features. This is matched by an ambiguous clinical and immunological phenotype that dismantles the classical antithetic dualism of gain- versus loss-of-function. Germline STAT3 mutation-related disease represents a pathological spectrum with the p.R335W associated phenotype locating between the 2 recognized clinical disease patterns.

Identifiants

pubmed: 35750105
pii: S0091-6749(22)00837-5
doi: 10.1016/j.jaci.2022.06.007
pii:
doi:

Substances chimiques

STAT3 Transcription Factor 0
Interleukin-6 0
STAT3 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1237-1241.e3

Informations de copyright

Copyright © 2022 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Auteurs

Lorenzo Lodi (L)

Department of Health Sciences, University of Florence, Florence, Italy; Immunology Unit, Department of Pediatrics, Meyer Children's Hospital, Florence, Florence, Italy.

Laura Eva Faletti (LE)

Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Freiburg, Germany; Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Maria Elena Maccari (ME)

Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Freiburg, Germany; Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Filippo Consonni (F)

Department of Health Sciences, University of Florence, Florence, Italy.

Miriam Groß (M)

Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Freiburg, Germany; Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Ilaria Pagnini (I)

Rheumatology Unit, Department of Pediatrics, Meyer Children's Hospital, Florence, Florence, Italy.

Silvia Ricci (S)

Department of Health Sciences, University of Florence, Florence, Italy; Immunology Unit, Department of Pediatrics, Meyer Children's Hospital, Florence, Florence, Italy. Electronic address: silvia.ricci@unifi.it.

Maximilian Heeg (M)

Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Freiburg, Germany; Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Gabriele Simonini (G)

Rheumatology Unit, Department of Pediatrics, Meyer Children's Hospital, Florence, Florence, Italy; NEUROFARBA Department, University of Florence, Florence, Italy.

Chiara Azzari (C)

Department of Health Sciences, University of Florence, Florence, Italy; Immunology Unit, Department of Pediatrics, Meyer Children's Hospital, Florence, Florence, Italy.

Stephan Ehl (S)

Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Freiburg, Germany; Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH